Redefining the Role of Etoposide in Peripheral T-Cell Lymphoma Treatment

Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Redefining the Role of Etoposide in First-Line Treatment of Peripheral T-Cell Lymphoma

Blood advances
Hematology
2017English

Chidamide in the Treatment of Peripheral T-Cell Lymphoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Recent Advances in the Treatment of Peripheral T‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2018English

Angioimmunoblastic T-Cell Lymphoma: A Rare Subtype of Peripheral T-Cell Lymphoma

Clinical Case Reports
Medicine
2018English

Therapeutic Options in Peripheral T Cell Lymphoma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Prognostic Markers in Peripheral T-Cell Lymphoma

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2010English

Peripheral T-Cell Lymphoma Mimicking Marginal Zone B-Cell Lymphoma

Modern Pathology
Forensic MedicinePathology
2002English

Forodesine in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma: An Evidence-Based Review

OncoTargets and Therapy
OncologyPharmacology
2018English

FDA Approval Summary: Brentuximab Vedotin in First‐Line Treatment of Peripheral T‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy